IP Library Granted Patent US 9,073,821
Granted Patent B2
US 9,073,821 · App. 13/642,320 · Granted Jul 7, 2015

Hydroxamic acid derivative

Inventors: Hajime Takashima (Tokyo, JP); Risa Tsuruta (Tokyo, JP); Tetsuya Yabuuchi (Tokyo, JP); Yusuke Oka (Tokyo, JP); Hiroki Urabe (Tokyo, JP); Yoichiro Suga (Tokyo, JP); Masato Takahashi (Tokyo, JP); Fumito Uneuchi (Tokyo, JP); Hironori Kotsubo (Toyama, JP); Muneo Shoji (Toyama, JP); Yasuko Kawaguchi (Toyama, JP)
Assignees: TAISHO PHARMACEUTICAL CO., LTD; TOYAMA CHEMICAL CO., LTD.
C07C259/06C07C271/22C07C271/28C07C311/08C07C317/28C07C317/44C07C323/41C07C323/62C07C2101/02C07C2101/04C07C2101/08C07C2101/14C07C2101/16C07C2101/18C07C2102/08C07D205/04C07D205/12C07D207/10C07D207/12C07D207/27C07D207/327C07D209/08C07D209/12C07D209/14C07D209/44C07D209/52C07D211/14C07D211/18C07D211/38C07D211/46C07D211/56C07D211/70C07D213/38C07D213/40C07D213/54C07D213/61C07D213/64C07D213/65C07D213/70C07D213/74C07D213/81C07D215/14C07D217/04C07D217/12C07D231/12C07D231/56C07D233/61C07D235/04C07D257/04C07D261/08C07D263/14C07D263/32C07D263/56C07D265/30C07D265/38C07D267/10C07D271/12C07D277/20C07D277/30C07D277/62C07D277/66C07D285/12C07D295/08C07D295/12C07D295/14C07D295/16C07D305/06C07D305/08C07D307/14C07D307/18C07D307/52C07D307/54C07D307/78C07D307/82C07D307/87C07D309/04C07D309/14C07D317/30C07D317/60C07D319/18C07D319/20C07D333/24C07D405/06C07D413/06C07D471/04C07D471/10C07D487/08C07D491/20C07D498/08C07F9/091
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,073,821
App. No.
13/642,320
Granted
Jul 7, 2015
Kind
B2
Abstract

Provided is a novel compound which is useful as a pharmaceutical composition by inhibiting an LpxC activity, thereby exhibiting potent antimicrobial activity against gram-negative bacteria including Pseudomonas aeruginosa and its drug resistant bacteria. Provided is a hydroxamic acid derivative represented by the following general formula [1] or a pharmaceutically acceptable salt thereof:

Claims (120)

1. A compound represented by the following formula [1] or a pharmaceutically acceptable salt thereof:

wherein

R 1 and R 2 are the same or different and each represent a hydrogen atom, a C 1-6 alkyl group, a C 3-8 cycloalkyl group or a C 1-6 alkoxy group (the C 1-6 alkyl group, the C 1-6 alkoxy group and the C 3-8 cycloalkyl group may be substituted with 1 to 3 substituents which are the same or different and are selected from “a halogen atom, a hydroxy group, a C 3-8 cycloalkyl group, a C 1-6 alkoxy group, a C 3-8 cycloalkoxy group, an amino group, a C 1-6 alkylamino group, a di(C 1-6 alkyl)amino group, —N(R 11 )COR 12 , —N(R 11 )SO 2 R 12 , a cyano group, a carboxy group, a carbamoyl group, —CON(R 13 )(R 14 ), —SO 2 N(R 13 )(R 14 ), a C 1-6 alkylthio group, a C 1-6 alkylsulfonyl group, an aryloxy group, an aryl group, and a heterocyclic group”),

R 11 , R 12 , R 13 and R 14 are the same or different and each represent a hydrogen atom or a C 1-6 alkyl group,

R 13 and R 14 , together with the nitrogen atom to which they are attached, may form a saturated or unsaturated 5- or 6-membered ring which may further contain one or more nitrogen atoms, oxygen atoms or sulfur atoms,

R 3 represents a hydrogen atom or a C 1-6 alkyl group (the C 1-6 alkyl group may be substituted with 1 to 3 substituents which are the same or different and are selected from “a halogen atom, a hydroxy group, a C 1-6 alkoxy group, a C 3-8 cycloalkoxy group, an amino group, a C 1-6 alkylamino group, and a di(C 1-6 alkyl)amino group”),

R 4 represents

a hydrogen atom,

a hydroxy group,

a C 1-6 alkoxy group,

a C 3-8 cycloalkoxy group,

an amino group,

a C 1-6 alkylamino group,

a di(C 1-6 alkyl)amino group,

a C 1-6 alkyl group, a C 3-8 cycloalkyl group

(the C 1-6 alkyl group and the C 3-8 cycloalkyl group may be substituted with 1 to 3 substituents which are the same or different and are selected from

“a halogen atom, a hydroxy group, a C 3-8 cycloalkyl group, a C 1-6 alkoxy group, a C 3-8 cycloalkoxy group, an amino group, a C 1-6 alkylamino group, a di(C 1-6 alkyl)amino group, —N(R 41 )COR 42 , —N(R 41 )SO 2 R 42 , a cyano group, a carboxy group, —CON(R 43 )(R 44 ), —SO 2 N(R 43 )(R 44 ), a C 1-6 alkylthio group, a C 1-6 alkylsulfonyl group, an aryl group, an aryloxy group, and a heterocyclic group (the aryl group, the aryloxy group, and the heterocyclic group may be substituted with 1 to 3 substituents which are the same or different and are selected from “a halogen atom, a C 1-6 alkyl group, a C 3-8 cycloalkyl group, a benzyl group, a C 1-6 haloalkyl group, a C 1-6 hydroxyalkyl group, a C 2-8 alkoxyalkyl group, a hydroxy group, a C 1-6 alkoxy group, a C 3-8 cycloalkoxy group, an amino group, a C 1-6 alkylamino group, a di(C 1-6 alkyl)amino group, —N(R 45 )COR 46 , —N(R 45 )SO 2 R 46 , a cyano group, a carboxy group, —CON(R 47 )(R 48 ), —SO 2 N(R 47 )(R 48 ), a C 1-6 alkylthio group, and a C 1-6 alkylsulfonyl group”) ”),

an aryl group, or a heterocyclic group

(the aryl group and the heterocyclic group may be substituted with 1 to 3 substituents which are the same or different and are selected from “a halogen atom, a C 1-6 alkyl group, a C 3-8 cycloalkyl group, a C 1-6 haloalkyl group, a C 1-6 hydroxyalkyl group, a C 2-8 alkoxyalkyl group, a hydroxy group, a C 1-6 alkoxy group, a C 3-8 cycloalkoxy group, an amino group, a C 1-6 alkylamino group, a di(C 1-6 alkyl)amino group, —N(R 45 )COR 46 , —N(R 45 )SO 2 R 46 , a cyano group, a carboxy group, —CON(R 47 )(R 48 ), —SO 2 N(R 47 )(R 48 ), a C 1-6 alkylthio group, and a C 1-6 alkylsulfonyl group”),

R 41 , R 42 , R 43 , R 44 , R 45 , R 46 , R 47 and R 48 are the same or different and each represent a hydrogen atom or a C 1-6 alkyl group,

R 43 and R 44 , together with the nitrogen atom to which they are attached, may form a saturated or unsaturated 5- or 6-membered ring which may further contain one or more nitrogen atoms, oxygen atoms or sulfur atoms,

R 47 and R 48 , together with the nitrogen atom to which they are attached, may form a saturated or unsaturated 5- or 6-membered ring which may further contain one or more nitrogen atoms, oxygen atoms or sulfur atoms,

R 3 and R 4 , together with the nitrogen atom to which they are attached, may form a saturated or unsaturated 5- or 6-membered ring which may further contain one or more nitrogen atoms, oxygen atoms or sulfur atoms,

A 1 represents a divalent aryl group which may be substituted with 1 to 4 substituents which are the same or different and are selected from the following group of substituents, R a ):

the group of substituents, R a , consists of a halogen atom, a hydroxy group, an amino group (the amino group may be substituted with a C 2-6 alkanoyl group or one or two C 1-6 alkyl groups), a carboxy group, a carbamoyl group, a C 1-6 alkyl group, a C 3-8 cycloalkyl group, a C 2-6 alkenyl group, and a C 1-6 alkoxy group (the C 1-6 alkyl group, the C 3-8 cycloalkyl group, the C 2-6 alkenyl group, and the C 1-6 alkoxy group may be substituted with 1 to 4 substituents which are the same or different and are selected from “a halogen atom, a hydroxy group, an amino group, a carboxy group, a C 1-6 alkylaminocarbonyl group, and a C 1-6 alkoxycarbonyl group”),

L represents —C≡C—, —C≡C—C≡C—, —CH═CH—, —CH═CH—C≡C—, or —C≡C—CH═CH—,

R 5 represents a hydrogen atom, a C 1-6 alkyl group, a C 3-8 cycloalkyl group, or an aryl group,

m denotes 1, 2 or 3,

A 2 represents a divalent aryl group which may be substituted with 1 to 4 substituents which are the same or different and are selected from the following group of substituents, R b ):

the group of substituents, R b , consists of a halogen atom, an optionally protected hydroxy group, a mercapto group, a cyano group, a nitro group, an optionally protected amino group, an optionally protected formyl group, an optionally protected carboxy group, a carbamoyl group, a sulfo group, a ureido group, a guanidido group, a C 1-6 alkyl group, a C 3-8 cycloalkyl group, a C 1-6 haloalkyl group, a C 1-6 hydroxyalkyl group, a C 1-6 alkoxy group, a C 1-6 alkylamino group, a di(C 1-6 alkyl)amino group, a C 1-6 alkoxycarbonyl group, a C 2-6 alkanoyl group, and an aryl group,

W represents R 6 —X 1 —, R 6 —X 2 —Y 1 —X 1 —, R 6 —X 4 —Y 1 —X 2 —Y 3 —X 3 —, Q-X 1 —Y 2 —X 3 —, or Q-X 1 —Y 1 —X 2 —Y 3 —X 3 —,

Y 2 represents —O—, —NR 7 —, —CO—, —NR 7 CO—, —CONR 7 —, —S(O) n —, —OCO—, —COO—, —NR 7 SO 2 —, —SO 2 —NR 7 —, —OCOO—, —OCONR 7 —, —NR 7 CONR 8 —, or a bond,

Y 1 and Y 3 are the same or different and each represent —O—, —NR 7 —, —CO—, —NR 7 CO—, —CONR 7 —, —S(O) n —, —OCO—, —COO—, —NR 7 SO 2 —, —SO 2 NR 7 —, —OCOO—, —OCONR 7 —, or —NR 7 CONR 8 —,

n denotes 0, 1 or 2,

X 1 and X 3 are the same or different and each represent a C 1-10 alkylene group, a C 2-10 alkenylene group, a C 2-10 alkynylene group, a C 3-8 cycloalkylene group, —C 1-6 alkylene-C 3-8 cycloalkylene-C 1-6 alkylene- (the C 1-10 alkylene group, the C 2-10 alkenylene group, the C 2-10 alkynylene group, the C 3-8 cycloalkylene group, and the —C 1-6 alkylene-C 3-8 cycloalkylene-C 1-6 alkylene- may be substituted with 1 to 4 substituents which are the same or different and are selected from a group of substituents, R c , to be shown below), or a bond,

X 2 and X 4 are the same or different and each represent a C 1-10 alkylene group, a C 2-10 alkenylene group, a C 2-10 alkynylene group, or —C 1-6 alkylene-C 3-8 cycloalkylene-C 1-6 alkylene-(the C 1-10 alkylene group, the C 2-10 alkenylene group, the C 2-10 alkynylene group, and the -C 1-6 alkylene-C 3-8 cycloalkylene-C 1-6 alkylene- may be substituted with 1 to 4 substituents which are the same or different and are selected from the group of substituents, R c , to be shown below),

Q represents a C 3-8 cycloalkyl group, an aryl group, or a heterocyclic group (the C 3-8 cycloalkyl group, the aryl group and the heterocyclic group may be substituted with 1 to 4 substituents which are the same or different and are selected from the group of substituents, R c , to be shown below, and the heterocyclic group may have the different carbon atoms on the ring bridged with a C 1-6 alkylene group or —C 1-6 alkylene-O—C 1-6 alkylene-),

R 6 represents a hydrogen atom, a halogen atom, an optionally protected hydroxy group, a mercapto group, a cyano group, a nitro group, an optionally protected amino group, an optionally protected formyl group, an optionally protected carboxy group, a carbamoyl group, a sulfo group, an optionally protected phosphate group, a ureido group, a guanidido group, R 7 —O—NR 8 —CO—, R 8 —ON═CR 9 —, R 8 —ON═CR 9 —NH—, R 7 —O—NR 8 —CH═N—, (R 7 )(R 8 )N—N═CH—, R 8 —O—NR 8 —, N≡C—NR 8 — or a C 1-6 alkoxy group (the C 1-6 alkoxy group may be substituted with 1 to 3 hydroxy groups),

R 7 and R 8 are the same or different and each represent a hydrogen atom, a C 1-6 alkyl group, a C 3-8 cycloalkyl group, an aryl group, or a heterocyclic group (the C 1-6 alkyl group, the C 3-8 cycloalkyl group, the aryl group and the heterocyclic group may be substituted with 1 to 4 substituents which are the same or different and are selected from the group of substituents, R c , to be shown below),

R 9 represents a hydrogen atom, a C 1-6 alkyl group, a C 3-8 cycloalkyl group, an amino group, or a C 1-6 alkylamino group, and

the group of substituents, R c , consists of a halogen atom, a hydroxy group, a cyano group, a nitro group, an amino group (the amino group may be substituted with a C 2-6 alkanoyl group or one or two C 1-6 alkyl groups), a carboxy group, a carbamoyl group, a ureido group, a guanidido group, a C 1-6 alkyl group (the C 1-6 alkyl group may be substituted with a heterocyclic group), a C 1-6 hydroxyalkyl group, a C 1-6 haloalkyl group, a C 3-8 cycloalkyl group, a C 1-6 alkoxy group (the C 1-6 alkoxy group may be substituted with 1 to 3 substituents which are the same or different and are selected from a hydroxy group, a halogen atom, a C 3-8 cycloalkyl group, a C 1-6 alkoxy group, an aryl group and a heterocyclic group), a C 3-8 cycloalkoxy group, a C 1-6 alkoxycarbonyl group, a C 1-6 alkoxycarbonylamino group, a C 2-6 alkanoyl group, a C 1-6 alkylsulfonyl group, a C 1-6 alkylthio group, an aryl group, a heterocyclic group (the aryl group and the heterocyclic group may be substituted with 1 to 4 substituents which are the same or different and are selected from “a halogen atom, a hydroxy group, a cyano group, a nitro group, an amino group, a carboxy group and a C 1-6 alkyl group”), a C 1-6 alkylidene group (the C 1-6 alkylidene group may be substituted with a C 1-6 alkoxy group), a C 3-8 cycloalkylidene group, a monocyclic saturated heterocyclidene group (the monocyclic saturated heterocyclidene group may be substituted with 1 to 2 C 1-6 alkyl groups), and a hydroxyaminocarbonyl group.

2. The compound represented by the following formula [1] or the pharmaceutically acceptable salt thereof, according to claim 1 :

wherein

R 1 and R 2 are the same or different and each represent a hydrogen atom, a C 1-6 alkyl group, a C 3-8 cycloalkyl group or a C 1-6 alkoxy group (the C 1-6 alkyl group, the C 1-6 alkoxy group and the C 3-8 cycloalkyl group may be substituted with 1 to 3 substituents which are the same or different and are selected from “a halogen atom, a hydroxy group, a C 3-8 cycloalkyl group, a C 1-6 alkoxy group, a C 3-8 cycloalkoxy group, an amino group, a C 1-6 alkylamino group, a di(C 1-6 alkyl)amino group, —N(R 11 )COR 12 , —N(R 11 )SO 2 R 12 , a cyano group, a carboxy group, a carbamoyl group, —CON(R 13 )(R 14 ), —SO 2 N(R 13 )(R 14 ), a C 1-6 alkylthio group, a C 1-6 alkylsulfonyl group, an aryloxy group, an aryl group, and a heterocyclic group”),

R 11 , R 12 , R 13 and R 14 are the same or different and each represent a hydrogen atom or a C 1-6 alkyl group,

R 13 and R 14 , together with the nitrogen atom to which they are attached, may form a saturated or unsaturated 5- or 6-membered ring which may further contain one or more nitrogen atoms, oxygen atoms or sulfur atoms,

R 3 represents a hydrogen atom or a C 1-6 alkyl group (the C 1-6 alkyl group may be substituted with 1 to 3 substituents which are the same or different and are selected from “a halogen atom, a hydroxy group, a C 1-6 alkoxy group, a C 3-8 cycloalkoxy group, an amino group, a C 1-6 alkylamino group, and a di(C 1-6 alkyl)amino group”),

R 4 represents

a hydrogen atom,

a hydroxy group,

a C 1-6 alkoxy group,

a C 3-8 cycloalkoxy group,

an amino group,

a C 1-6 alkylamino group,

a di(C 1-6 alkyl)amino group,

a C 1-6 alkyl group, a C 3-8 cycloalkyl group

(the C 1-6 alkyl group and the C 3-8 cycloalkyl group may be substituted with 1 to 3 substituents which are the same or different and are selected from

“a halogen atom, a hydroxy group, a C 3-8 cycloalkyl group, a C 1-6 alkoxy group, a C 3-8 cycloalkoxy group, an amino group, a C 1-6 alkylamino group, a di(C 1-6 alkyl)amino group, —N(R 41 )COR 42 , —N(R 41 )SO 2 R 42 , a cyano group, a carboxy group, —CON(R 43 )(R 44 ), —SO 2 N(R 43 )(R 44 ), a C 1-6 alkylthio group, a C 1-6 alkylsulfonyl group, an aryl group, an aryloxy group, and a heterocyclic group (the aryl group, the aryloxy group, and the heterocyclic group may be substituted with 1 to 3 substituents which are the same or different and are selected from “a halogen atom, a C 1-6 alkyl group, a C 3-8 cycloalkyl group, a benzyl group, a C 1 -6 haloalkyl group, a C 1-6 hydroxyalkyl group, a C 2-8 alkoxyalkyl group, a hydroxy group, a C 1-6 alkoxy group, a C 3-8 cycloalkoxy group, an amino group, a C 1-6 alkylamino group, a di(C 1-6 alkyl)amino group, —N(R 45 )COR 46 , —N(R 45 )SO 2 R 46 , a cyano group, a carboxy group, —CON(R 47 )(R 48 ), —SO 2 N(R 47 )(R 48 ), a C 1-6 alkylthio group, and a C 1-6 alkylsulfonyl group”) ”),

an aryl group, or a heterocyclic group

(the aryl group and the heterocyclic group may be substituted with 1 to 3 substituents which are the same or different and are selected from “a halogen atom, a C 1-6 alkyl group, a C 3-8 cycloalkyl group, a C 1-6 haloalkyl group, a C 1-6 hydroxyalkyl group, a C 2-8 alkoxyalkyl group, a hydroxy group, a C 1-6 alkoxy group, a C 3-8 cycloalkoxy group, an amino group, a C 1-6 alkylamino group, a di(C 1-6 alkyl)amino group, —N(R 45 )COR 46 , —N(R 45 )SO 2 R 46 , a cyano group, a carboxy group, —CON(R 47 )(R 48 ), —SO 2 N(R 47 )(R 48 )SO 2 N(R 47 )(R 48 ), a C 1-6 alkylthio group, and a C 1-6 alkylsulfonyl group”),

R 41 , R 42 , R 43 , R 44 , R 45 , R 46 , R 47 and R 48 are the same or different and each represent a hydrogen atom or a C 1-6 alkyl group,

R 43 and R 44 , together with the nitrogen atom to which they are attached, may form a saturated or unsaturated 5- or 6-membered ring which may further contain one or more nitrogen atoms, oxygen atoms or sulfur atoms,

R 47 and R 48 , together with the nitrogen atom to which they are attached, may form a saturated or unsaturated 5- or 6-membered ring which may further contain one or more nitrogen atoms, oxygen atoms or sulfur atoms,

R 3 and R 4 , together with the nitrogen atom to which they are attached, may form a saturated or unsaturated 5- or 6-membered ring which may further contain one or more nitrogen atoms, oxygen atoms or sulfur atoms,

A 1 represents a divalent aryl group which may be substituted with 1 to 4 substituents which are the same or different and are selected from the following group of substituents, R a ):

the group of substituents, R a , consists of a halogen atom, a hydroxy group, an amino group (the amino group may be substituted with a C 2-6 alkanoyl group or one or two C 1-6 alkyl groups), a carboxy group, a carbamoyl group, a C 1-6 alkyl group, a C 3-8 cycloalkyl group, a C 2-6 alkenyl group, and a C 1-6 alkoxy group (the C 1-6 alkyl group, the C 3-8 cycloalkyl group, the C 2-6 alkenyl group, and the C 1-6 alkoxy group may be substituted with 1 to 4 substituents which are the same or different and are selected from “a halogen atom, a hydroxy group, an amino group, a carboxy group, a C 1-6 alkylaminocarbonyl group, and a C 1-6 alkoxycarbonyl group”),

L represents —C≡C— or —C≡C—C≡C—,

R 5 represents a hydrogen atom, a C 1-6 alkyl group, a C 3-8 cycloalkyl group, or an aryl group,

m denotes 1, 2 or 3,

A 2 represents a divalent aryl group which may be substituted with 1 to 4 substituents which are the same or different and are selected from the following group of substituents, R b ):

the group of substituents, R b , consists of a halogen atom, an optionally protected hydroxy group, a mercapto group, a cyano group, a nitro group, an optionally protected amino group, an optionally protected formyl group, an optionally protected carboxy group, a carbamoyl group, a sulfo group, a ureido group, a guanidido group, a C 1-6 alkyl group, a C 3-8 cycloalkyl group, a C 1-6 haloalkyl group, a C 1-6 hydroxyalkyl group, a C 1-6 alkoxy group, a C 1-6 alkylamino group, a di(C 1-6 alkyl)amino group, a C 1-6 alkoxycarbonyl group, a C 2-6 alkanoyl group, and an aryl group,

W represents R 6 —X 1 —, R 6 —X 2 —Y 1 —X 1 —, R 6 —X 4 —Y 1 —X 2 —Y 3 —X 3 —, Q-X 1 —Y 2 —X 3 —, or Q-X 1 —Y 1 —X 2 —Y 3 —X 3 —,

Y 2 represents —O—, —NR 7 —, —CO—, —NR 7 CO—, —CONR 7 —, —S(O) n —, —OCO—, —COO—, —NR 7 SO 2 —, —SO 2 —NR 7 —, —OCOO—, —OCONR 7 —, —NR 7 —CONR 8 —, or a bond,

Y 1 and Y 3 are the same or different and each represent —O—, —NR 7 —, —CO—, —NR 7 CO—, —CONR 7 —, —S(O) n —, —OCO—, —COO—, —NR 7 SO 2 , —SO 2 NR 7 —, —OCOO—, —OCONR 7 —, or —NR 7 CONR 8 —,

n denotes 0, 1 or 2,

X 1 and X 3 are the same or different and each represent a C 1-10 alkylene group, a C 2-10 alkenylene group, a C 2-10 alkynylene group (the C 1-10 alkylene group, the C 2-10 alkenylene group and the C 2-10 alkynylene group may be substituted with 1 to 4 substituents which are the same or different and are selected from a group of substituents, R c , to be shown below), or a bond,

X 2 and X 4 are the same or different and each represent a C 1-10 alkylene group, a C 2-10 alkenylene group, a C 2-10 alkynylene group, or -C 1-6 alkylene-C 3-8 cycloalkylene-C 1-6 alkylene -(the C 1-10 alkylene group, the C 2-10 alkenylene group, the C 2-10 alkynylene group, and the -C 1-6 alkylene-C 3-8 cycloalkylene-C 1-6 alkylene—may be substituted with 1 to 4 substituents which are the same or different and are selected from the group of substituents, R c , to be shown below),

Q represents a C 3-8 cycloalkyl group, an aryl group, or a heterocyclic group (the C 3-8 cycloalkyl group, the aryl group and the heterocyclic group may be substituted with 1 to 4 substituents which are the same or different and are selected from the group of substituents, R c , to be shown below),

R 6 represents a hydrogen atom, a halogen atom, an optionally protected hydroxy group, a mercapto group, a cyano group, a nitro group, an optionally protected amino group, an optionally protected formyl group, an optionally protected carboxy group, a carbamoyl group, a sulfo group, an optionally protected phosphate group, a ureido group, a guanidido group, R 7 —O—NR 8 —CO—, R 8 —ON═CR 9 —, R 8 —ON═CR 9 —NH—, R 7 —O—NR 8 —CH═N—, (R 7 )(R 8 )N—N═CH—, R 8 —O—NR 8 —, or N≡C—NR 8 —,

R 7 and R 8 are the same or different and each represent a hydrogen atom, a C 1-6 alkyl group, a C 3-8 cycloalkyl group, an aryl group, or a heterocyclic group (the C 1-6 alkyl group, the C 3-8 cycloalkyl group, the aryl group and the heterocyclic group may be substituted with 1 to 4 substituents which are the same or different and are selected from the group of substituents, R c , to be shown below),

R 9 represents a hydrogen atom, a C 1-6 alkyl group, a C 3-8 cycloalkyl group, an amino group, or a C 1-6 alkylamino group, and

the group of substituents, R c , consists of a halogen atom, a hydroxy group, a cyano group, a nitro group, an amino group (the amino group may be substituted with a C 2-6 alkanoyl group or one or two C 1-6 alkyl groups), a carboxy group, a carbamoyl group, a ureido group, a guanidido group, a C 1-6 alkyl group (the C 1-6 alkyl group may be substituted with a heterocyclic group), a C 1-6 hydroxyalkyl group, a C 1-6 haloalkyl group, a C 3-8 cycloalkyl group, a C 1-6 alkoxy group (the C 1-6 alkoxy group may be substituted with 1 to 3 hydroxy groups), a C 3-8 cycloalkoxy group, a C 1-6 alkoxycarbonyl group, a C 1-6 alkoxycarbonylamino group, a C 2-6 alkanoyl group, a C 1-6 alkylsulfonyl group, a C 1-6 alkylthio group, an aryl group, and a heterocyclic group (the aryl group and the heterocyclic group may be substituted with 1 to 4 substituents which are the same or different and are selected from “a halogen atom, a hydroxy group, a cyano group, a nitro group, an amino group, a carboxy group and a C 1-6 alkyl group”).

3. The compound or the pharmaceutically acceptable salt thereof, according to claim 1 , wherein R 1 is a hydrogen atom or a C 1-6 alkyl group (the C 1-6 alkyl group may be substituted with the same or different 1 to 3 halogen atoms).

4. The compound or the pharmaceutically acceptable salt thereof, according to claim 3 , wherein R 1 is a C 1-6 alkyl group (the C 1-6 alkyl group may be substituted with the same or different 1 to 3 halogen atoms).

5. The compound or the pharmaceutically acceptable salt thereof, according to claim 4 , wherein R 1 is a methyl group.

6. The compound or the pharmaceutically acceptable salt thereof, according to claim 1 , wherein R 2 is a hydrogen atom.

7. The compound or the pharmaceutically acceptable salt thereof, according to claim 1 , wherein R 2 is a methyl group.

8. The compound or the pharmaceutically acceptable salt thereof, according to claim 1 , wherein

R 3 is a hydrogen atom, and

R 4 is a C 1-6 alkyl group (the C 1-6 alkyl group may be substituted with a phenyl group or a monocyclic aromatic heterocyclic group (the phenyl group and the monocyclic aromatic heterocyclic group may be substituted with 1 to 3 substituents which are the same or different and are selected from “a halogen atom, a C 1-6 alkyl group, a C 3-8 cycloalkyl group, a C 1-6 haloalkyl group, a C 1-6 hydroxyalkyl group, a C 2-8 alkoxyalkyl group, a hydroxy group, a C 1-6 alkoxy group, a C 3-8 cycloalkoxy group, an amino group, a C 1-6 alkylamino group, a di(C 1-6 alkyl)amino group, —N(R 45 )COR 46 , —CON(R 47 )(R 48 )”)).

9. The compound or the pharmaceutically acceptable salt thereof, according to claim 8 , wherein R 3 is a hydrogen atom, and R 4 is a methyl group.

10. The compound or the pharmaceutically acceptable salt thereof, according to claim 1 , wherein A 1 is a phenylene group (the phenylene group may be substituted with 1 to 4 substituents which are the same or different and are selected from “a halogen atom, a hydroxy group, an amino group and a C 1-6 alkyl group”).

11. The compound or the pharmaceutically acceptable salt thereof, according to claim 10 , wherein A 1 is a phenylene group.

12. The compound or the pharmaceutically acceptable salt thereof, according to claim 1 , wherein L is —C≡C—.

13. The compound or the pharmaceutically acceptable salt thereof, according to claim 1 , wherein

W is R 6 —X 1 —,

X 1 is a methylene group or a bond,

R 6 is a hydrogen atom, an optionally protected hydroxy group, or R 8 —ON═CR 9 —,

R 8 is a hydrogen atom or a C 1-6 alkyl group (the C 1-6 alkyl group may be substituted with 1 to 4 substituents which are the same or different and are selected from a group of substituents, R c , to be shown below),

R 9 is a hydrogen atom, a C 1-6 alkyl group, a C 3-8 cycloalkyl group, an amino group, or a C 1-6 alkylamino group, and

the group of substituents, R c , consists of a halogen atom and a hydroxy group.

14. The compound or the pharmaceutically acceptable salt thereof, according to claim 1 , wherein

W is R 6 —X 2 —Y 1 —X 1 —,

Y 1 is —O— or —NR 7 —,

X 1 is a methylene group, an ethylene group (the methylene group and the ethylene group may be substituted with 1 to 2 methyl groups), a C 3-8 cycloalkylene group, or a bond,

X 2 is a C 1-4 alkylene group (the C 1-4 alkylene group may be substituted with 1 to 4 substituents which are the same or different and are selected from a group of substituents, R c , to be shown below),

R 6 is a hydrogen atom, a halogen atom, an optionally protected hydroxy group, or a C 1-6 alkoxy group,

R 7 is a hydrogen atom, a C 1-6 alkyl group or a C 3-8 cycloalkyl group (the C 1-6 alkyl group and the C 3-8 cycloalkyl group may be substituted with 1 to 4 substituents which are the same or different and are selected from the following group of substituents, R c ), and

the group of substituents, R c , consists of a halogen atom, a hydroxy group, and a C 1-6 alkyl group.

15. The compound or the pharmaceutically acceptable salt thereof, according to claim 1 , wherein

W is Q-X 1 —Y 2 —X 3 —,

Y 2 is —O—, —NR 7 —, or a bond,

X 1 is a C 1-4 alkylene group (the C 1-4 alkylene group may be substituted with 1 to 4 substituents which are the same or different and are selected from a group of substituents, R c , to be shown below), or a bond,

X 3 is a methylene group, an ethylene group (the methylene group and the ethylene group may be substituted with 1 to 2 methyl groups), a C 3-8 cycloalkylene group, or a bond,

Q is a C 3-8 cycloalkyl group, an aryl group, or a heterocyclic group (the C 3-8 cycloalkyl group, the aryl group, or the heterocyclic group may be substituted with 1 to 4 substituents which are the same or different and are selected from the group of substituents, R c , shown below

R 7 is a hydrogen atom, a C 1-6 alkyl group or a C 3-8 cycloalkyl group (the C 1-6 alkyl group and the C 3-8 cycloalkyl group may be substituted with 1 to 4 substituents which are the same or different and are selected from the following group of substituents, R c ), and

the group of substituents, R c , consists of a halogen atom, a hydroxy group, a C 1-6 alkyl group, a C 1-6 hydroxyalkyl group, a C 1-6 haloalkyl group, a C 3-8 cycloalkyl group, a C 1-6 alkoxy group (the C 1-6 alkoxy group may be substituted with 1 to 3 hydroxy groups or halogen atoms), a C 3-8 cycloalkoxy group, a C 2-6 alkanoyl group, a C 1-6 alkylidene group (the C 1-6 alkylidene group may be substituted with a C 1-6 alkoxy group), and a hydroxyaminocarbonyl group.

16. The compound or the pharmaceutically acceptable salt thereof, according to claim 1 , wherein

W is a hydrogen atom, a halogen atom, a C 1-6 alkyl group, a C 1-6 alkoxy group, or a C 1-6 alkylamino group (the C 1-6 alkyl group, the C 1-6 alkoxy group and the C 1-6 alkylamino group may be substituted with 1 to 3 substituents which are the same or different and are selected from “a halogen atom, a hydroxy group, a C 1-6 alkoxy group and a morpholino group”).

17. A pharmaceutical composition comprising the compound or the pharmaceutically acceptable salt thereof according to claim 1 and a pharmaceutically acceptable carrier, excipient or diluent.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2012
From: TAKASHIMA, HAJIME; TSURUTA, RISA; YABUUCHI, TETSUYA; OKA, YUSUKE; URABE, HIROKI; SUGA, YOICHIRO; TAKAHASHI, MASATO; UNEUCHI, FUMITO; KOTSUBO, HIRONORI; SHOJI, MUNEO; KAWAGUCHI, YASUKO
To: TAISHO PHARMACEUTICAL CO., LTD.; TOYAMA CHEMICAL CO., LTD.
Reel/Frame 029332/0237 →
Priority Claims (1)
JP 2010-096852 · Apr 20, 2010 · national
Continuity (1)
Related Publication 20130072677A1 · Mar 21, 2013